Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06292533

Effectiveness of Ultrapulse for the Treatment of Androgenic Alopecia Among Malaysian: A Quasi-experimental Study

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
92 (estimated)
Sponsor
Universiti Tunku Abdul Rahman · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to to evaluate the effectiveness of Ultrapulse for the treatment of androgenic alopecia among Malaysian. The main questions it aims to answer are: * the efficacy of Ultrapulse in treatment of androgenic alopecia among Malaysian * the safety and adverse effect of Ultrapulse treatment. * the quality of life of androgenic alopecia among Malaysian.

Detailed description

Ultrapulse is a is a laser beauty device using erbium-doped yttrium aluminium garnet laser (er:YAG). Er:YAG laser is a laser with wavelength of 2940nm which is able to penetrate into the dermis to a depth of 3-4 mm, and energy absorption occurs in the area of the dermal papilla, resulting in an increase in blood circulation of the papilla and activation of metabolism in the hair follicle. It generates multiple micro pores at the epidermal layer that enhances the absorption of the active substances that help to stimulate hair growth developed by Lyzer Co. Ltd in Korea.

Conditions

Interventions

TypeNameDescription
DEVICEEr:YAG laserUltrapulse is a is a laser beauty device using erbium-doped yttrium aluminium garnet laser (er:YAG). Er:YAG laser is a laser with wavelength of 2940nm which is able to penetrate into the dermis to a depth of 3-4 mm, and energy absorption occurs in the area of the dermal papilla, resulting in an increase in blood circulation of the papilla and activation of metabolism in the hair follicle.

Timeline

Start date
2024-12-01
Primary completion
2025-08-01
Completion
2025-12-01
First posted
2024-03-05
Last updated
2024-12-18

Locations

1 site across 1 country: Malaysia

Source: ClinicalTrials.gov record NCT06292533. Inclusion in this directory is not an endorsement.